Cook J J, Haynes K M, Werther G A
Department of Endocrinology and Diabetes, Royal Children's Hospital, Melbourne, Australia.
J Clin Invest. 1988 Jan;81(1):206-12. doi: 10.1172/JCI113296.
We examined human growth hormone's (hGH) effect on mitogenesis in cultured human fibroblasts, and the role of local insulin-like growth factor I (IGF-I). With 0.5% human hypopituitary serum (HPS), hGH increased thymidine incorporation (TI) over serum-free medium dose responsively, with half-maximal effect at 10 ng/ml (0.5 nM) (hGH 127 +/- 8.8%; IGF-I 107 +/- 1.7% [SEM]) (n = 10). Similarly, with 0.5% HPS, hGH and IGF-I increased cell replication by 172 +/- 8.2% and 169 +/- 25%, respectively (n = 4). Specific IGF-I monoclonal antibody (Sm1.2) dose dependently blunted TI stimulated by 10 ng/ml hGH or IGF-I (at 1:1000, 38 +/- 6.5% and 30 +/- 14% reduction, respectively). Sm1.2 also reduced cell replication by both 10 ng/ml hGH and IGF-I, respectively, to 32% and 42% of stimulated values. Dexamethasone (0.1 microM) synergistically enhanced TI by both IGF-I and hGH. A 28-h time course for TI showed that hGH stimulated a similar peak to IGF-I, lagging in its effect by 4-10 h. We have provided further evidence that hGH stimulates growth of cultured human fibroblasts via local IGF-I production, consistent with IGF-I's paracrine-autocrine role.
我们研究了人生长激素(hGH)对培养的人成纤维细胞有丝分裂的影响,以及局部胰岛素样生长因子I(IGF-I)的作用。在含有0.5%人垂体功能减退血清(HPS)的情况下,与无血清培养基相比,hGH能剂量依赖性地增加胸腺嘧啶核苷掺入(TI),在10 ng/ml(0.5 nM)时达到最大效应的一半(hGH为127±8.8%;IGF-I为107±1.7%[标准误])(n = 10)。同样,在含有0.5% HPS的情况下,hGH和IGF-I分别使细胞复制增加了172±8.2%和169±25%(n = 4)。特异性IGF-I单克隆抗体(Sm1.2)能剂量依赖性地减弱10 ng/ml hGH或IGF-I刺激的TI(在1:1000时,分别降低38±6.5%和30±14%)。Sm1.2还分别将10 ng/ml hGH和IGF-I刺激的细胞复制降低至刺激值的32%和42%。地塞米松(0.1 microM)能协同增强IGF-I和hGH的TI。TI的28小时时间进程显示,hGH刺激的峰值与IGF-I相似,但其效应滞后4 - 10小时。我们提供了进一步的证据,表明hGH通过局部产生IGF-I刺激培养的人成纤维细胞生长,这与IGF-I的旁分泌 - 自分泌作用一致。